Close
0
You have no items in your order cart.
Search
Filters

Bovilis Ibr Marker Live - 20ml

For the active immunisation of cattle to reduce the intensity and duration of the clinical respiratory signs induced by an infection with BHV-1 and to reduce nasal excretion of field virus.

Dosage: a single dose of 2 ml reconstituted vaccine per animal.
For intranasal or intramuscular administration.
Brand: MSD
Availability: In stock
SKU: 108741
Product tags
Customers who bought this item also bought

Bovipast RSP - 50ml

199380
For the active immunisation of cattle against
• Parainfluenza3 virus (PI3 virus), to reduce infections.
• Bovine Respiratory Syncytial Virus (BRSV) to reduce infection and clinical signs.
• Mannheimia (Pasteurella) haemolytica serotype A1, to reduce infection, mortality, clinical signs, lung lesions and bacterial invasion of the lung caused by serotypes A1 and A6. Cross-reactive immunity to the A6 serotype of M. haemolytica has been demonstrated in a challenge experiment under laboratory conditions after a primary course of vaccination.

Approximately two weeks after completion of the basic immunisation programme, the humoral immune response against BRS-Virus and PI3-Virus is at its highest level.

The duration of protective immunity has not been established in challenge experiments.

Dosage & Administration:
Vaccination dose: 5 ml by subcutaneous injection at the side of the neck.

Bovilis Ibr Marker Live - 100ml

118131
For the active immunisation of cattle to reduce the intensity and duration of the clinical respiratory signs induced by an infection with BHV-1 and to reduce nasal excretion of field virus.

Dosage: a single dose of 2 ml reconstituted vaccine per animal.
For intranasal or intramuscular administration.

Bovilis Ibr Marker Live - 10ml

102661
For the active immunisation of cattle to reduce the intensity and duration of the clinical respiratory signs induced by an infection with BHV-1 and to reduce nasal excretion of field virus.

Dosage: a single dose of 2 ml reconstituted vaccine per animal.

For intranasal or intramuscular administration.

Bravecto - 1000mg - Single

118654
Chewable tablets containing fluralaner for the treatment and prevention of flea and tick infestations in dogs. Bravecto is a chewable tablet for dogs containing fluralaner. It is for the treatment and prevention of flea and tick infestations in dogs, for the treatment of demodicosis caused by Demodex canis and for the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation in dogs.

Last up 12 weeks.

The following tablet strengths are:
Bravecto 112.5 mg chewable tablets for very small dogs (2-4.5 kg)
Bravecto 250 mg chewable tablets for small dogs (>4.5-10 kg)
Bravecto 500 mg chewable tablets for medium-sized dogs (>10-20 kg)
Bravecto 1000 mg chewable tablets for large dogs (>20-40 kg)
Bravecto 1400 mg chewable tablets for very large dogs (>40-56 kg).